| Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries: a modelling study F Debellut, A Clark, C Pecenka, J Tate, R Baral, C Sanderson, U Parashar, ... The Lancet Global Health 7 (12), e1664-e1674, 2019 | 53 | 2019 |
| Cost of illness for childhood diarrhea in low-and middle-income countries: a systematic review of evidence and modelled estimates R Baral, J Nonvignon, F Debellut, SA Agyemang, A Clark, C Pecenka BMC Public Health 20, 1-13, 2020 | 52 | 2020 |
| Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines C Pecenka, F Debellut, N Bar-Zeev, P Anwari, J Nonvignon, ... Vaccine 36 (49), 7472-7478, 2018 | 37 | 2018 |
| Improving influenza surveillance in sub-Saharan Africa C Steffen, F Debellut, BD Gessner, FC Kasolo, AA Yahaya, N Ayebazibwe, ... Bulletin of the World Health Organization 90 (4), 301-305, 2012 | 37 | 2012 |
| Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study F Debellut, A Clark, C Pecenka, J Tate, R Baral, C Sanderson, U Parashar, ... The Lancet Global Health 9 (7), e942-e956, 2021 | 22 | 2021 |
| Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of ROTARIX and ROTAVAC F Debellut, S Jaber, Y Bouzya, J Sabbah, M Barham, F Abu-Awwad, ... PLoS One 15 (2), e0228506, 2020 | 21 | 2020 |
| Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan P Anwari, F Debellut, C Pecenka, SM Parwiz, A Clark, D Groman, N Safi Vaccine 36 (51), 7769-7774, 2018 | 20 | 2018 |
| Potential health impact and cost-effectiveness of bivalent human papillomavirus (HPV) vaccination in Afghanistan P Anwari, F Debellut, E Vodicka, A Clark, F Farewar, ZA Zhwak, D Nazary, ... Vaccine 38 (6), 1352-1362, 2020 | 18 | 2020 |
| Forecasting demand for maternal influenza immunization in low-and lower-middle-income countries F Debellut, N Hendrix, JR Ortiz, P Lambach, KM Neuzil, N Bhat, ... PLoS One 13 (6), e0199470, 2018 | 16 | 2018 |
| Cost-effectiveness analysis of the implementation of a National Immunization Program for rotavirus vaccination in a country with a low rotavirus gastroenteritis-related … H Lee, SY Park, A Clark, F Debellut, C Pecenka, DS Kim, HM Kim, JH Kim, ... Vaccine 37 (35), 4987-4995, 2019 | 15 | 2019 |
| Projected impact, cost-effectiveness, and budget implications of rotavirus vaccination in Mongolia ME Lusvan, F Debellut, A Clark, S Demberelsuren, D Otgonbayar, ... Vaccine 37 (6), 798-807, 2019 | 15 | 2019 |
| Economic evaluation of rotavirus vaccination in children of Bhutan ACG Luz, N Luangasanatip, P Kingkaew, D Adhikari, W Isaranuwatchai, ... Vaccine 38 (32), 5049-5059, 2020 | 14 | 2020 |
| Direct and indirect costs of acute diarrhea in children under five years of age in Indonesia: health facilities and community survey JA Thobari, AWE Mulyadi, E Watts, N Carvalho, F Debellut, A Clark, ... The Lancet Regional Health–Western Pacific 19, 2022 | 13 | 2022 |
| A review of the economic evidence of typhoid fever and typhoid vaccines K Luthra, E Watts, F Debellut, C Pecenka, N Bar-Zeev, D Constenla Clinical Infectious Diseases 68 (Supplement_2), S83-S95, 2019 | 13 | 2019 |
| Potential impact and cost-effectiveness of injectable next-generation rotavirus vaccines in 137 LMICs: a modelling study F Debellut, C Pecenka, WP Hausdorff, A Clark Human vaccines & immunotherapeutics 18 (1), 2040329, 2022 | 12 | 2022 |
| Forecasting demand for the typhoid conjugate vaccine in low-and middle-income countries F Debellut, N Hendrix, VE Pitzer, KM Neuzil, D Constenla, N Bar-Zeev, ... Clinical Infectious Diseases 68 (Supplement_2), S154-S160, 2019 | 12 | 2019 |
| Cost-effectiveness analysis for rotavirus vaccine decision-making: How can we best inform evolving and complex choices in vaccine product selection? C Pecenka, F Debellut, N Bar-Zeev, P Anwari, J Nonvignon, A Clark Vaccine 38 (6), 1277, 2020 | 11 | 2020 |
| Estimating the economic burden of typhoid in children and adults in Blantyre, Malawi: A costing cohort study F Limani, C Smith, R Wachepa, H Chafuwa, J Meiring, P Noah, P Patel, ... PloS one 17 (11), e0277419, 2022 | 6 | 2022 |
| Projecting the cost of introducing typhoid conjugate vaccine (TCV) in the national immunization program in Malawi using a standardized costing framework F Debellut, R Mkisi, V Masoo, M Chisema, D Mwagomba, M Mtenje, ... Vaccine 40 (12), 1741-1746, 2022 | 5 | 2022 |
| Does anybody want an injectable rotavirus vaccine, and why? Understanding the public health value proposition of next-generation rotavirus vaccines WP Hausdorff, J Price, F Debellut, J Mooney, AA Torkelson, K Giorgadze, ... Vaccines 10 (2), 149, 2022 | 5 | 2022 |
